title: Women with chronic hepatitis C virus infection: recommendations for clinical practice.
abstract: The natural history of hepatitis C virus infection differs between women and men. Women demonstrate a slow rate of disease progression until menopause. Older women are more likely to develop fibrosis and are less responsive than younger women to pegylated interferon and ribavirin. Women of childbearing age have higher rates of sustained virologic response, but current therapies are contraindicated during pregnancy. Vertical transmission of hepatitis C virus occurs, but data supporting recommendations for prevention of mother-to-infant transmission are limited.
authors.affiliation: Veterans Affairs Medical Center, Jackson, MS 39216, USA. mary.burton2@va.gov
authors.forename: Mary Jane
authors.initials: MJ
authors.lastname: Burton
authors.forename: James B
authors.initials: JB
authors.lastname: Brock
authors.forename: Stephen A
authors.initials: SA
authors.lastname: Geraci
mesh_terms: D000328:Adult; D000367:Age Factors; D000998:Antiviral Agents / Q000627:therapeutic use; D002985:Clinical Protocols; D005260:Female; D019698:Hepatitis C, Chronic / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000628:therapy*; D012737:Sex Factors
chemical_list: D000998:Antiviral Agents